RNMBF(RNMBF)
RNMBF
No analyst ratings available
No analyst price targets available for RNMBF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $14.16B | $19.06B | $25.28B | $33.13B | $42.54B |
| Low | $13.83B | $17.38B | $23.75B | $31.13B | $39.97B |
| High | $14.69B | $20.35B | $26.67B | $34.95B | $44.88B |
| EBITDA Avg | $2.41B | $3.24B | $4.30B | $5.63B | $7.23B |
| Low | $2.35B | $2.96B | $4.04B | $5.29B | $6.80B |
| High | $2.50B | $3.46B | $4.53B | $5.94B | $7.63B |
| EBIT Avg | $1.83B | $2.46B | $3.27B | $4.28B | $5.50B |
| Low | $1.79B | $2.25B | $3.07B | $4.02B | $5.16B |
| High | $1.90B | $2.63B | $3.45B | $4.52B | $5.80B |
| Net Income Avg | $1.16B | $1.70B | $2.34B | $3.02B | $3.89B |
| Low | $1.07B | $1.56B | $2.16B | $2.78B | $3.59B |
| High | $1.25B | $1.82B | $2.51B | $3.23B | $4.17B |
| EPS Avg | $37.98 | $55.39 | $76.58 | $98.58 | $127.18 |
| Low | $35.01 | $51.05 | $70.58 | $90.85 | $117.21 |
| High | $40.70 | $59.35 | $82.06 | $105.62 | $136.27 |
| Analysts (Rev / EPS) | 20 / 1 | 19 / 1 | 8 / 1 | 9 / 1 | 15 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $3.21B | $6.06B |
| Low | $3.19B | $5.98B |
| High | $3.24B | $6.13B |
| EBITDA Avg | $546M | $1.03B |
| Low | $542M | $1.02B |
| High | $550M | $1.04B |
| EBIT Avg | $415M | $783M |
| Low | $412M | $773M |
| High | $418M | $793M |
| Net Income Avg | $324M | $1.03B |
| Low | $319M | $1.01B |
| High | $328M | $1.04B |
| EPS Avg | $6.95 | $22.07 |
| Low | $6.85 | $21.76 |
| High | $7.04 | $22.38 |
| Analysts (Rev / EPS) | 2 / 1 | 2 / 1 |